Literature DB >> 8996604

Mechanism of action of topoisomerase II-targeted antineoplastic drugs.

N Osheroff1, A H Corbett, M J Robinson.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 8996604     DOI: 10.1016/s1054-3589(08)61134-5

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


× No keyword cloud information.
  20 in total

1.  Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes.

Authors:  Michael J Mitchell; Carlos A Castellanos; Michael R King
Journal:  J Nanomater       Date:  2012       Impact factor: 2.986

2.  Multipotent hematopoietic cells susceptible to alternative double-strand break repair pathways that promote genome rearrangements.

Authors:  Richard Francis; Christine Richardson
Journal:  Genes Dev       Date:  2007-05-01       Impact factor: 11.361

3.  Topoisomerase II-mediated site-directed alkylation of DNA by psorospermin and its use in mapping other topoisomerase II poison binding sites.

Authors:  Y Kwok; Q Zeng; L H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

4.  Structure and conformational changes of DNA topoisomerase II visualized by electron microscopy.

Authors:  P Schultz; S Olland; P Oudet; R Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  In the presence of subunit A inhibitors DNA gyrase cleaves DNA fragments as short as 20 bp at specific sites.

Authors:  H Gmünder; K Kuratli; W Keck
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

6.  E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells.

Authors:  Michael J Mitchell; Christina S Chen; Varun Ponmudi; Andrew D Hughes; Michael R King
Journal:  J Control Release       Date:  2012-03-01       Impact factor: 9.776

7.  Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors.

Authors:  Michael J Mitchell; Michael R King
Journal:  New J Phys       Date:  2013-01-18       Impact factor: 3.729

8.  Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor.

Authors:  Xianke Zeng; Hua Zhang; Annabell Oh; Yan Zhang; Douglas Yee
Journal:  Breast Cancer Res Treat       Date:  2011-08-18       Impact factor: 4.872

9.  Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients.

Authors:  Matija Rijavec; Mira Silar; Nadja Triller; Izidor Kern; Urška Cegovnik; Mitja Košnik; Peter Korošec
Journal:  Pathol Oncol Res       Date:  2011-04-01       Impact factor: 3.201

10.  Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis.

Authors:  Samuel A Burns; R Lee Archer; Janet A Chavis; Cameron A Tull; Lori L Hensley; Paul D Drew
Journal:  Brain Res       Date:  2012-08-02       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.